April 11, 2019
Altimmune To Present NasoVAX Phase 2 Data at the World Vaccine Congress in Washington, D.C.
Media
April 10, 2019
ACTIVE REMODELING OF CERAMENT® INTO HUMAN BONE CONFIRMED IN UK STUDY
April 10, 2019
Additional patent protection for melflufen granted in the US until 2033
April 10, 2019
Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL
April 09, 2019
Targovax ASA: Annual Report 2018
April 03, 2019
Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
April 02, 2019
MIPS continues to be confident about its leading technology
April 02, 2019
Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours presented at TAT11
April 01, 2019
Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing
April 01, 2019
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update
